Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Inorg Chem ; 61(34): 13591-13599, 2022 Aug 29.
Article in English | MEDLINE | ID: mdl-35976691

ABSTRACT

A two-dimensional (2D) Janus film with self-assembled gold nanoparticles (AuNPs) is a class of fascinating materials that may offer unprecedented opportunities to realize diverse applications due to their two distinct faces with anisotropic properties. In this work, we report a novel, straightforward strategy for the preparation of a bilayer coordination nanosheet (CONASH)/AuNP Janus film, where the CONASH features infinite trinuclear gold(I) pyrazolate cyclic complexes with electron-accepting viologen as bridges. The bilayer film has visible light absorption and redox properties and showcased promising photocatalytic H2 evolution activity by virtue of the formed unique heterojunction structure between AuNPs and CONASH. The current study opens a novel pathway for controlled fabrication of the 2D Janus film with assembled AuNPs for photocatalytic applications.

2.
Dis Markers ; 2022: 9781913, 2022.
Article in English | MEDLINE | ID: mdl-35620272

ABSTRACT

[This corrects the article DOI: 10.1155/2019/5093803.].

3.
Front Psychol ; 12: 717336, 2021.
Article in English | MEDLINE | ID: mdl-34867595

ABSTRACT

The purpose of this study was to analyze the current situation of the entrepreneurial consciousness of college student entrepreneurs and to explore the role of innovative and entrepreneurial talents in social and economic development. Based on the teaching concept of Chinese excellent traditional culture, first, the relevant theories of innovation and entrepreneurship, as well as the characteristics of entrepreneurial talents in colleges and entrepreneurs, are analyzed and elaborated; moreover, the definition of college student entrepreneur is explained; then, from the perspective of entrepreneurial teaching management, entrepreneurial education, and place support, the questionnaire method is selected to show the understanding of the entrepreneurship of college students; finally, based on the Cobb-Douglas function, the model before and after the introduction of innovative and entrepreneurial talents is tested and analyzed. Investigation and analysis suggest that most college students have entrepreneurial intention, and 61.5% of them choose to start their own business after having working experience; the relative freedom of time and space is the main factor to attract college students to start their own businesses, accounting for 42.3%; 69.3% of college students think that capital is a restricting factor for entrepreneurship, while 76.2% think that lack of experience is a major restricting factor for entrepreneurship; college students have a certain demand for entrepreneurship training and guidance from the school, especially in the setting of entrepreneurship incubation park and resource pool; the characteristics of entrepreneurship, professional skills, and interpersonal resources are more crucial for college students; most college students have a positive cognition of the excellent traditional Chinese teaching concepts; the analysis based on the Cobb-Douglas function reveals that the introduction of innovative and entrepreneurial talents can promote economic development. This exploration has a positive effect on the cultivation of awareness of college students of entrepreneurship and innovation, as well as the relationship discussion between the introduction of innovative and entrepreneurial talents and social economy.

4.
Mol Med ; 27(1): 131, 2021 10 19.
Article in English | MEDLINE | ID: mdl-34666672

ABSTRACT

BACKGROUND: Myocardial dysfunction caused by sepsis (SIMD) leads to high mortality in critically ill patients. We investigated the function and mechanism of long non-coding RNA MAPKAPK5-AS1 (lncRNA MAPKAPK-AS1) on lipopolysaccharide (LPS)-induced inflammation response in vivo and in vitro. METHOD: Male SD rats were utilized for in vivo experiments. Rat cardiomyocytes (H9C2) were employed for in vitro experiments. Western blotting was employed to measure protein expression, and RT-PCR was performed to measure mRNA expression of inflammation factors. TUNEL and flow cytometry were carried out to evulate cell apoptosis. RESULT: The results showed that the expression of MAPKAPK5-AS1 was increased, while the expression of miR-124-3p was decreased in the inflammatory damage induced by LPS in vivo and in vitro. Knockdown of MAPKAPK5-AS1 reduced LPS-induced cell apoptosis and inflammation response, while overexpression of miR-124-3p weakened the effects of MAPKAPK5-AS1 knockdown on LPS-induced cell apoptosis and inflammation response. Moreover, miR-124-3p was identified as a downstream miRNA of MAPKAPK5-AS1, and E2F3 was a target of miR-214-3p. MAPKAPK5-AS1 knockdown increased the expression of miR-124-3p, while miR-124-3p overexpression reduced the expression of MAPKAPK5-AS1. In addition, miR-124-3p was found to downregulate E2F3 expression in H9C2 cells. CONCLUSION: MAPKAPK5-AS1/miR-124-3p/E2F3 axis regulates LPS-related H9C2 cell apoptosis and inflammatory response.


Subject(s)
E2F3 Transcription Factor/genetics , Gene Expression Regulation , Inflammation/genetics , MicroRNAs/genetics , Myocardium/metabolism , RNA, Long Noncoding/genetics , Animals , Apoptosis/genetics , Blotting, Western , Cell Line , Cell Survival/genetics , Cytokines/metabolism , E2F3 Transcription Factor/metabolism , Humans , Inflammation/chemically induced , Inflammation/metabolism , Lipopolysaccharides , Male , Myocardium/pathology , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , RNA Interference , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction
5.
Medicine (Baltimore) ; 99(34): e21843, 2020 Aug 21.
Article in English | MEDLINE | ID: mdl-32846832

ABSTRACT

RATIONALE: Hypertrophic cardiomyopathy (HCM) is an inherited myocardial disease and a common cause of sudden cardiac death, heart failure, atrial fibrillation and stroke. In families affected by HCM, genotyping is useful for identifying susceptible relatives. In the present study, we investigated the disease-causing mutations in a three-generation Chinese family with HCM using whole exome sequencing (WES). PATIENT CONCERNS: The proband, a 50-year-old man, was diagnosed with HCM at the age of 41 years. He presented with an asymmetric hypertrophic interventricular septum and a maximum interventricular septum thickness of 18.04 mm. His third elder sister, niece and daughter were also clinically affected by HCM. DIAGNOSIS: Autosomal dominant HCM. INTERVENTIONS: Seven family members, including 4 affected members, accepted WES. The genetic variants were subsequently called using Genome Analysis Toolkit and annotated using the InterVar program. Following frequency filtration by the Genome Aggregation Database, the variants were evaluated using an in-house bioinformatics analysis pipeline. OUTCOMES: HCM was transmitted as an autosomal dominant trait in the family. An extremely rare stop gained mutation, rs796925245 (g.1:201359630G>A, c.835C>T, p.Gln279Ter) in the troponin T2 (TNNT2) gene was identified as the disease-causing mutation. The stop gained mutation was predicted to result in a truncated troponin T protein in cardiac sarcomere. An adolescent family member who had normal echocardiographic measurements was found to carry the same disease-causing mutation. LESSONS: A novel nonsense TNNT2 mutation was identified as the HCM-causing mutation in this Chinese pedigree. Since HCM shows a low penetrance by clinical criteria in adolescents, the adolescent mutation carrier, who is still clinically unaffected, should be offered routine follow-ups and sport activity recommendations to prevent adverse events including sudden cardiac death in the future.


Subject(s)
Cardiomyopathy, Hypertrophic, Familial/genetics , Troponin T/genetics , Adolescent , Adult , Aged , Asian People/genetics , Cardiomyopathy, Hypertrophic, Familial/complications , Cardiomyopathy, Hypertrophic, Familial/diagnosis , Codon, Nonsense , Death, Sudden, Cardiac/etiology , Echocardiography/methods , Female , Humans , Hypertrophy/diagnostic imaging , Male , Middle Aged , Pedigree , Phenotype , Ventricular Septum/pathology , Exome Sequencing/methods
6.
Life Sci ; 249: 117476, 2020 May 15.
Article in English | MEDLINE | ID: mdl-32119962

ABSTRACT

Mangiferin is a well-known xanthone extracted from mango leaves (Mangifera indica Linn). Mangiferin is widely distributed in the bark, peel, leaf, seed, stalk, and kernel of mango and higher plants. The pharmacological properties of mangiferin, including its antioxidant, anticancer, antiaging, antiviral, hepatoprotective, analgesic, and immunomodulatory activities, have been described in several studies. We investigated the effect of mangiferin on isoproterenol-induced apoptosis. Experimental heart failure was induced in rats by intraperitoneal administration of isoproterenol (5 mg/kg) for 7 consecutive days. Rats were divided into five groups: group I (sham rats), group II (isoproterenol alone control), group III (isoproterenol + 25 mg/kg mangiferin), group IV (isoproterenol + 50 mg/kg mangiferin), and group V (isoproterenol + 0.0225 mg/kg digitalis as a positive control). Hemodynamic parameters and body weight, heart weight and liver weight, apoptosis induction, and caspase-3, Bax, and Bcl-2 protein levels were measured, and a histopathological analysis of cardiomyocytes was performed. In addition, apoptosis and protein expression of caspase-3, cleaved caspase-3, Bax, and Bcl-2 were measured in cardiac H9c2 cells. Mangiferin supplementation significantly increased heart rate and improved the maximum rate of decrease in left ventricular (LV) pressure, the maximum rate of increase in LV pressure, and LV systolic pressure. Mangiferin reduced inflammatory cell infiltration and the number of broken myocardial fibers, and decreased apoptosis in cardiomyocytes by reducing proteins levels of caspase-3 and Bax and increasing those of Bcl-2. Our findings suggest that mangiferin has a cardioprotective effect against isoproterenol-induced apoptosis in cardiomyocytes.


Subject(s)
Apoptosis/drug effects , Cardiotonic Agents/pharmacology , Heart Failure/chemically induced , Heart/drug effects , Xanthones/pharmacology , Animals , Cardiotonic Agents/administration & dosage , Injections, Intraperitoneal , Isoproterenol/administration & dosage , Isoproterenol/pharmacology , Rats
7.
Int J Mol Med ; 45(1): 195-209, 2020 01.
Article in English | MEDLINE | ID: mdl-31746373

ABSTRACT

The progressive loss of cardiomyocytes caused by cell death leads to cardiac dysfunction and heart failure (HF). Rapamycin has been shown to be cardioprotective in pressure­overloaded and ischemic heart diseases by regulating the mechanistic target of rapamycin (mTOR) signaling network. However, the impact of rapamycin on cardiomyocyte death in chronic HF remains undetermined. Therefore, in the current study we addressed this issue using a rat myocardial infarction (MI)­induced chronic HF model induced by ligating the coronary artery. Following surgery, rats were randomly divided into six groups, including the sham­, vehicle­ and rapamycin­operated groups, at 8 or 12 weeks post­MI. A period of 4 weeks after MI induction, the rats were treated with rapamycin (1.4 mg­kg­day) or vehicle for 4 weeks. Cardiac function was determined using echocardiography, the rats were subsequently euthanized and myocardial tissues were harvested for histological and biochemical analyses. In the cell culture experiments with H9c2 rat cardiomyocytes, apoptosis was induced using angiotensin II (100 nM; 24 h). Cardiomyocyte apoptosis and autophagy were assessed via measuring apoptosis­ and autophagy­associated proteins. The activities of mTOR complex 1 (mTORC1) and mTORC2 were evaluated using the phosphorylation states of ribosomal S6 protein and Akt, respectively. The activity of the endoplasmic reticulum (ER) stress pathway was determined using the levels of GRP78, caspase­12, phospho­JNK and DDIT3. Echocardiographic and histological measurements indicated that rapamycin treatment improved cardiac function and inhibited cardiac remodeling at 8 weeks post­MI. Additionally, rapamycin prevented cardiomyocyte apoptosis and promoted autophagy at 8 weeks post­MI. Rapamycin treatment for 4 weeks inhibited the mTOR and ER stress pathways. Furthermore, rapamycin prevented angiotensin II­induced H9c2 cell apoptosis and promoted autophagy by inhibiting the mTORC1 and ER stress pathways. These results demonstrated that rapamycin reduced cardiomyocyte apoptosis and promoted cardiomyocyte autophagy, by regulating the crosstalk between the mTOR and ER stress pathways in chronic HF.


Subject(s)
Apoptosis/drug effects , Autophagy/drug effects , Heart Failure/etiology , Heart Failure/metabolism , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Signal Transduction/drug effects , Sirolimus/pharmacology , TOR Serine-Threonine Kinases/metabolism , Angiotensin II/metabolism , Animals , Cell Line , Echocardiography , Endoplasmic Reticulum Stress/drug effects , Fluorescent Antibody Technique , Heart Failure/diagnosis , Male , Rats
8.
Dis Markers ; 2019: 5093803, 2019.
Article in English | MEDLINE | ID: mdl-31885737

ABSTRACT

Circulating microRNAs (miRNAs) have been proposed as potential biomarkers for left ventricular remodeling in postinfarction heart failure (HF). However, the diagnostic reproducibility of the use of circulating miRNAs may be affected by the temporal expression of miRNAs following myocardial infarction (MI). In the current study, using a MI-induced HF rat cohort (4-, 8-, and 12-week post-MI groups), we investigated the temporal expression of plasma miRNAs during the development of left ventricular remodeling. The plasma miRNA expression profile was obtained using miRNA sequencing. The expression of candidate miRNAs in plasma and tissues was examined with real-time PCR. Target genes of candidate miRNAs were predicted using a parallel miRNA-messenger RNA expression profiling approach. The value of plasma miRNAs as biomarkers for left ventricular remodeling was evaluated in patients with postinfarction HF (n = 32) and control patients with stable angina and without significant coronary lesions and HF (n = 16) with real-time PCR. Although the expression levels of miR-20a-5p, miR-340-5p, and let-7i-5p were temporally regulated in plasma, myocardium, and peripheral blood mononuclear cells, the expression levels of plasma miRNAs, especially miR-20a-5p, were associated with the development of left ventricular remodeling in the postinfarction HF rat cohort. The target genes of these 3 miRNAs were associated with the mechanistic target of rapamycin, nuclear factor-κB, tumour necrosis factor, apoptosis, and p53 signaling pathways. Additionally, the plasma levels of miR-20a-5p, miR-340-5p, and let-7i-5p were significantly increased in patients with postinfarction HF. However, only the expression levels of miR-20a-5p presented significant positive correlations with left ventricular internal end diastolic dimension and left ventricular end diastolic volume. In conclusion, the expression levels of plasma miR-20a-5p were significantly associated with the degree of left ventricular dilatation, and plasma miR-20a-5p may be a potential biomarker for postinfarction left ventricular remodeling.


Subject(s)
Heart Failure/physiopathology , MicroRNAs/blood , Myocardial Infarction/complications , Ventricular Remodeling , Aged , Animals , Biomarkers/blood , Disease Models, Animal , Female , Gene Expression Profiling , Gene Expression Regulation , Heart Failure/etiology , Heart Failure/genetics , Humans , Male , Middle Aged , Myocardial Infarction/genetics , Rats , Sequence Analysis, RNA
9.
Medicine (Baltimore) ; 97(51): e13623, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30572474

ABSTRACT

RATIONALE: Anti-thrombosis therapy for atrial fibrillation (AF) management and stroke prevention is an important aspect of disease management. Novel oral anticoagulants (NOACs) are recommended by guidelines for AF management. However, if one can switch one NOAC to another when the former showed a poor effect has not been fully determined. PATIENT CONCERNS: A 52-year-old man was admitted to our center for heart failure and AF with a thrombus in the left atrium. DIAGNOSES: Cardiomyopathy was diagnosed by cardiac magnetic resonance (CMR) and echocardiography. INTERVENTIONS: He was prescribed rivaroxaban (20 mg daily) as treatment, and dabigatran (150 mg twice daily) was used when the thrombus was found to be non-response to rivaroxaban. OUTCOMES: The rivaroxaban did not diminish the atrial thrombus, and dabigatran was given instead which finally eliminated the thrombus. LESSONS: Individualized responsiveness to NOACs should be considered and paid more attention to during clinical practice.


Subject(s)
Antithrombins/therapeutic use , Atrial Fibrillation/drug therapy , Dabigatran/therapeutic use , Heart Diseases/drug therapy , Thrombosis/drug therapy , Atrial Fibrillation/etiology , Drug Resistance , Heart Atria , Heart Diseases/complications , Humans , Male , Middle Aged , Rivaroxaban/therapeutic use , Thrombosis/complications
10.
Thromb Res ; 136(5): 932-7, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26384442

ABSTRACT

BACKGROUND: The use of thrombolytic therapy in patients with intermediate-risk pulmonary embolism is controversial. To compare with anticoagulation alone, no analysis before has determined whether thrombolytic therapy is associated with improved survival or lower incidence of adverse clinical outcomes for intermediate-risk pulmonary embolism. OBJECTIVE: This meta-analysis was performed to assess mortality benefits, bleeding and recurrent pulmonary embolism risks associated with thrombolytic therapy compared with anticoagulation in patients with intermediate-risk pulmonary embolism. METHODS: The Web of Science, PubMed, Embase, EBSCO, and the Cochrane Library databases were searched for randomized clinical trials comparing thrombolytic therapy with anticoagulation in intermediate-risk pulmonary embolism patients (in which the mortality data were reported) from inception to August 5, 2014. Primary outcomes were all-cause mortality and major bleeding. Secondary outcomes were recurrent pulmonary embolism and minor bleeding. The pooled relative risk (RR), Mantel-Haenszel corresponding method and fixed-effect model were used to estimate the efficacy and safety of thrombolytic therapy with 95% confidence intervals. RESULTS: Eight clinical randomized controlled trials involving 1755 patients with intermediate-risk pulmonary embolism were included. Patients treated with thrombolytics presented lower mortality than patients in the anticoagulation cohort (RR, 0.52; 95% CI, 0.28-0.97; 1.39% [12/866] vs. 2.92% [26/889]). Compared with anticoagulation, thrombolytic therapy was associated with a higher risk of major (RR, 3.35; 95% CI, 2.03-5.54; 7.80% [64/820] vs. 2.28% [19/834]) and minor (RR, 3.66; 95% CI, 2.77-4.84; 32.78% [197/601] vs. 8.94% [53/593]) bleeding. Furthermore, thrombolytic therapy was associated with a lower incidence of recurrent pulmonary embolism (RR, 0.33; 95% CI, 0.15-0.73; 0.73% [6/826] vs. 2.72% [23/846]). CONCLUSION: Compared with anticoagulation, thrombolytic therapy in patients with intermediate-risk pulmonary embolism is associated with lower all-cause mortality and recurrent pulmonary embolism risk despite increased major and minor bleeding risks.


Subject(s)
Anticoagulants/therapeutic use , Hemorrhage/chemically induced , Pulmonary Embolism/drug therapy , Thrombolytic Therapy/methods , Humans , Pulmonary Embolism/mortality
11.
Exp Ther Med ; 7(4): 816-820, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24660029

ABSTRACT

Optimization of intratracheal instillation is necessary to establish an ideal animal model of acute lung injury (ALI) in order to further reveal the cellular and molecular pathogenesis of ALI. It is possible that instilling air from a prefilled syringe may promote the delivery of reagents into the alveolar spaces, resulting in different pulmonary responses. In the present study, the influence of instilling air by trans-tracheal intratracheal instillation in a lipopolysaccharide (LPS)-induced mouse model of ALI was investigated. The bronchoalveolar lavage (BAL) fluid biochemical index, BAL fluid differential cell counts, lung wet/dry weight ratio, lung histology and BAL fluid interleukin-8 (IL-8) levels were assessed 24 h subsequent to intratracheal instillation. Instilled air promoted LPS-induced ALI, as indicated by the severity of acute pulmonary inflammation and increased IL-8 release. In conclusion, this study indicates that instilled air may be used to improve the intratracheal instillation procedure and to establish a more reliable animal model of ALI.

SELECTION OF CITATIONS
SEARCH DETAIL
...